Israel Chemicals Ltd. provided capital expenditure guidance for the fiscal year 2017. For the year, the company plans to further reduce its CapEx in 2017, with an expected target range of $500 million to $550 million while still leaving room for asset improvement and growth as Asher mentioned earlier.